World’s First Portable Fingerprint Drug Test Now Available in Spain

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

The worlds first portable fingerprint-based drug test, which works by analysing sweat from a fingerprint to determine if someone has recently used cocaine, opiates, amphetamines or cannabis, is now available in Spain. Established drug testing specialist MTB Distribuciones has been appointed as the first Spanish distributor for the revolutionary fingerprint drug test, adding to the Intelligent Fingerprinting partner community covering the UK, Australia, New Zealand, Italy and the US.

Fingerprint testing is non-invasive, fast and cost-effective, making it an ideal solution to support drug testing programmes within the workplace “ on construction sites or within logistics organisations, for example. The solution is also being used by coroners to assist with toxicology tests and in the drug rehabilitation sector.

Ignasi Balsells who heads up MTB Distribuciones said: I was impressed with the Intelligent Fingerprinting technology after first seeing it at an exhibition last year, and Im delighted that our company is the first to bring the solution to Spain. In comparison with current saliva and urine-based approaches, the advantages of fingerprint testing are significant. It is clear that the fingerprint method is easy, quick and inexpensive to use, and we believe many organisations across Spain will find it a valuable and complementary approach when testing for drug use.

We are currently working across a range of markets, including workplace testing, drug rehabilitation operations and prisons to investigate opportunities. We also feel that the Intelligent Fingerprinting method could bring huge benefits in other markets. In hospital Accident & Emergency departments, for example, the test could be used to quickly establish if patients showing signs of altered mental status, such as confusion or hallucinations, might have taken drugs. Fingerprint testing is non-invasive, test samples can be collected in seconds, and results are available in minutes. All of these benefits combine to make a great solution for scenarios where volume drug testing is required, continued Ignasi Balsells.

Paul Yates, Intelligent Fingerprintings Business Development Director added: the network of international distributors selling our innovative solution is growing quickly, and weve now got coverage across the US, Australia, New Zealand, Italy and Spain. Were also looking forward to announcing further distribution agreements during 2019. MTB Distribuciones has a deep understanding of todays evolving drug testing needs, proven expertise across our target market sectors, and the vision to see how fingerprint-based drug testing can add value for the organisations it works with. We look forward to a successful partnership.

An introductory video demonstrating fingerprint-based drug testing in action is available here

Full story

Cheryl Billson

[email protected]
(0)7791 720460
Twitter @iFingerprinting


[email protected]
973 22 10 20.